Your Notifications
All done, no notifications

Papillary Thyroid Cancer Treatment Cost in South Korea

USD 6500 - USD 35000

Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs

2
Days in Hospital
2-4 hrs
Procedure Time
95 - 99%
Success Rate
JCI/ISO 100,000+ Patients 24X7 Coordinator Visa & Travel handled
Your all-in-one medical travel platform for treatment, recovery & care.

Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact
Connect with an Expert

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Estimated Treatment Cost
USD 6500 - USD 35000
All-inclusive • Hospital + Medications + Recovery Assistance + Dedicated Care Coordinator

International Quality. Affordable Care.

How Much Does Papillary Thyroid Cancer Treatment Cost in South Korea?

Papillary Thyroid Cancer Treatment in South Korea typically ranges between USD 6000 - USD 15000 depending on the patient's condition. Additionally, factors like the duration of treatment, the need for follow-up care, and the use of advanced technologies or specialised treatments can further influence the overall cost.

Factors Influencing the Cost of Papillary Thyroid Cancer Treatment in South Korea

  • Stage and Spread of Cancer: If treatment is performed on early-stage cancers, it could be less expensive. Later-stage metastatic cancers are hard to treat and thus, their therapy becomes costly.
  • Type of Treatment: Expenses also differ for surgery, radioactive iodine (RAI) therapy, hormone therapy, and regular follow-up tests.
  • Hospital and Experts: It may be more expensive if treated in a highly regarded hospital or by a very experienced surgeon.
  • Diagnostic Tests and Imaging: The costs increase with several tests- ultrasounds, CT scans, biopsies, and blood tests.
  • Post-treatment Medications and Follow-up: The medications needed for such long-term treatment for thyroid hormone replacement therapy and annual monitoring pose an added expense.

What's included in your Papillary Thyroid Cancer Treatment quote?

Papillary thyroid cancer treatment
fee, operating room charges, and hospital fees
Oncology team consults
Pre-evaluation, treatment planning, follow-ups
2–4-day hospital stay
management
5–7-day in-country follow-up
Pre-treatment investigations
Visa & medical-visa invite letter
Airport pickup & transfers

Cost of Papillary Thyroid Cancer Treatment in Major Cities of South Korea

CityCost (USD)
Seoul $6,000 – $15,000 Explore More

Papillary Thyroid Cancer Treatment - South Korea Vs the World

$0 - $0
$3k - $9k
$3k - $8k
$4k - $10k
$5k - $26k
$6k - $15k
$7k - $15k
$8k - $18k
$8k - $16k
$8k - $15k
$8k - $12k
$12k - $22k
$15k - $25k
Dr. Shagufta Parveen
Author

Doctor of Pharmacy

3 Years of Experience

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.

During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.

Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.

Her research work is accessible through the following links:

https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en

https://carcinogenesis.com/index.php/JOC/article/view/870

https://carcinogenesis.com/index.php/JOC/article/view/868

https://wjpsronline.com/abstract/0000000760

View More
Dr Prateek Varshney
Reviewer

Surgical Oncologist

15 Years of Experience

Last Reviewed - June 2026

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute.
View More

Need Help Choosing the Right Treatment? Talk to a Medical Advisor

Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.

15 min
Average response time

Serving Patients Worldwide in Multiple Languages.

Papillary thyroid cancer therapy oversees the management and removal of malignant cells from the thyroid gland. The treatment objectives are to destroy tumors, inhibit recurrences, and assist in normal hormone levels for a functioning body.

The goal of treatment for papillary thyroid cancer (PTC), the most prevalent kind of thyroid cancer, is to eradicate malignant cells, stop them from spreading or reoccurring, and preserve healthy hormone levels and neck function. Despite being highly curable and typically slow-growing, prompt action is crucial to lowering the risk of complications and ensuring long-term survival. Removing the tumour, reducing the chance of recurrence, and maintaining general quality of life are the main objectives of treatment.

If you experience chronic throat pain, hoarseness, difficulty swallowing, or a painless lump or swelling in your neck, consult a physician. These could indicate thyroid nodules, which can occasionally be malignant. Early detection makes better results and more conservative treatment possible. The endocrine specialists at MediGence can assist with quick diagnoses and individualised therapy regimens.

Thyroid function tests, fine-needle aspiration biopsies, neck ultrasonography, and, in certain situations, radioactive iodine scans or CT/MRI to determine local or distant spread are all part of the initial preparation. Your doctor will review your symptoms, current medications, and medical history. If surgery is scheduled, pre-operative blood tests and anaesthetic evaluations will also be carried out.

  • Thyroidectomy: The thyroid gland may be removed entirely or in part.
  • Dissection of Lymph Nodes: Excision of afflicted neighbouring lymph nodes.
  • Radioactive Iodine Therapy (RAI): After surgery, radioactive iodine therapy (RAI) destroys any leftover thyroid tissue.
  • Thyroid Hormone Therapy: TSH suppression and hormone replacement for life.
  • Radiation/Chemotherapy: Rarely used for aggressive or recurring instances is radiation or chemotherapy.

Recovery at home takes one to two weeks after a one to three-hour surgery and a brief hospital stay. Regular follow-ups and lifetime hormone therapy are necessary, with radioactive iodine administered if necessary after four to six weeks.

  • Surgical risks include infection, haemorrhage, low calcium, and hoarseness.
  • Risks associated with radioactive iodine include dry mouth, altered taste, neck enlargement, and transient infertility.
  • Long-Term Risks: Unbalanced hormones, infrequent occurrence or dissemination

Papillary thyroid carcinoma is highly curable with timely and effective therapy. Most patients can anticipate a high quality of life and long-term survival. Surgery is generally safe and effective when performed by skilled surgeons, and in higher-risk patients, radioactive iodine guarantees complete disease control. Hormone treatment helps avoid recurrence and preserve metabolic equilibrium.

Voice monitoring, wound care, and rest are all part of the recovery process following thyroid surgery. Medication for thyroid hormones starts soon after surgery. Usually, patients are told to refrain from strenuous exercise or heavy lifting for a few weeks. Routine follow-ups are crucial to tracking hormone levels and identifying any recurrent symptoms early.

The outcome for papillary thyroid carcinoma is excellent, particularly for individuals with localised illness who are younger than 55. Over 98% of people survive for five years. After treatment, most individuals have healthy lives. However, long-term care and routine monitoring are essential.

95–99%

Excellent long-term disease control

2–4 days

Typical hospital stay

2–4 weeks

to typical return to work
Explore Hospitals ( 2 )

Seoul, South Korea

2700+ Beds · 245+ Procedures
ISO
Starting
USD 15000

Seoul, South Korea

808+ Beds · 193+ Procedures
JCI
Starting
USD 6500

Get Your Papillary Thyroid Cancer Treatment
Plan in 24 hrs.

Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.

HIPAA-Compliant Data SecurityShared Only with Your Consent

Free Consultation No Obligation Personalized Treatment Plan Response Within 24 Hours

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.

Process Involved for Papillary Thyroid Cancer Treatment in South Korea

  • Diagnosis: The investigations include ultrasound, FNAC, CT scans, and thyroid function tests to identify the type of cancer and its staging.
  • Surgery (Thyroidectomy): Removal of part or all of the thyroid.
  • Radionuclide therapy with Radioiodine (RAI): The use of RAI is indicated if residual cancer cells could still exist after the surgery.
  • Thyroid hormone replacement: Lifelong maintenance of the hormone level in the body to prevent cancer recurrence.
  • Follow-Up Care: Regular visits, blood tests, and imaging for recovery assessment and detection of recurrence.
  • Papillary Thyroid Carcinoma (PTC)
  • Follicular Variant of Papillary Thyroid Cancer
  • Multifocal Papillary Thyroid Cancer
  • Metastatic Papillary Thyroid Cancer
  • Recurrent Papillary Thyroid Cancer
  • Patients undergoing biopsy for papillary thyroid carcinoma diagnosis.
  • Lymph node metastasis is not advanced in those cases where the tumor is limited to the thyroid.
  • Patients who are eligible for surgery and radioactive iodine therapy.
  • Individuals having recurrent or metastasised papillary thyroid cancer.
  • Total or Partial Thyroidectomy
  • Neck Lymph Node Dissection (if cancer has spread)
  • Radioactive Iodine (RAI) Therapy
  • Thyroid Hormone Replacement Therapy
  • Advanced Imaging and Blood Tests for Monitoring
  • Endocrinologist:
  • Surgical Oncologist:
  • Medical Oncologist:
  • Radiation Oncologist:
  • Rehabilitation Specialists
  • Fill out the inquiry form: Fill out the form to provide us with the relevant information about your condition.
  • Consult with Our Healthcare Expert: One of our qualified specialists will contact you for a consultation.
  • Receive a Detailed Treatment Plan: After examining your situation, we will provide you with a detailed treatment plan that includes expert views and cost breakdowns for various choices.
  • Choose your preferred option: Choose the therapy option that best suits you.
  • Seamless Organization: We will manage all the details, including visas, flights, accommodations, and transfers, for a stress-free journey.
Jenny Wilson
Your Dedicated Medical Patient Advisor
Treatment planning • Hospital coordination • Multilingual support • Response within 15 minutes.
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Patient Stories

Ms. Monica
Ms. Monica
Monica from Ghana for AV Malformation Treatment in India

Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing…

Silim Shabani
Silim Shabani
Patient Testimonial: Silim Shabani for Ovarian Cancer Treatment in Turkey

Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for…

Frequently Asked Questions

The cost of Papillary Thyroid Cancer Treatment in South Korea may vary depending on the stage of the cancer, tumour size, extent of disease, surgical approach, diagnostic investigations, hospital charges, surgeon and specialist consultation fees, radioactive iodine therapy, medications, and follow-up care. The overall cost may include consultations, imaging studies, biopsy, surgery, pathology, radioactive iodine treatment when indicated, thyroid hormone replacement therapy, hospitalisation, and long-term surveillance.MediGence can help international patients explore suitable cancer centres and obtain an estimated treatment plan based on the patient's diagnosis, cancer stage, and clinical requirements.

The best hospitals in South Korea for Papillary Thyroid Cancer Treatment are those with experienced endocrine surgeons, head and neck surgeons, endocrinologists, nuclear medicine specialists, radiation oncologists when required, pathologists, and multidisciplinary thyroid cancer teams. Patients should consider hospitals with comprehensive cancer centres, advanced diagnostic imaging, specialised thyroid surgery programmes, nuclear medicine facilities, and long-term thyroid cancer follow-up services.

Patients should choose an endocrine surgeon, head and neck surgeon, or endocrinologist experienced in the diagnosis and management of thyroid cancer. Important factors include experience in thyroidectomy, lymph node dissection, management of recurrent disease, radioactive iodine treatment planning, and long-term thyroid cancer surveillance.The treating team should assess tumour size, biopsy findings, ultrasound imaging, lymph node involvement, staging investigations, thyroid function, and overall health before recommending the most appropriate treatment plan.

Papillary Thyroid Cancer Treatment has an overall success rate of approximately 98%, depending on the stage of the disease, tumour size, lymph node involvement, presence of distant metastasis, patient age, and overall health. Papillary thyroid cancer generally has an excellent prognosis, particularly when diagnosed early and treated at experienced multidisciplinary thyroid cancer centres.

Hospitals in South Korea may use high-resolution neck ultrasound, fine-needle aspiration (FNA) biopsy, CT or MRI when indicated, PET-CT for selected cases, molecular testing, intraoperative nerve monitoring, minimally invasive thyroid surgery where appropriate, radioactive iodine (RAI) therapy, thyroid hormone suppression therapy, and long-term thyroglobulin monitoring.Treatment typically involves partial or total thyroidectomy, with or without lymph node dissection, followed by radioactive iodine therapy in selected patients. Long-term thyroid hormone replacement and regular follow-up are essential components of care.

Possible risks and complications may include:
  • Bleeding or haematoma
  • Surgical site infection
  • Temporary or permanent hoarseness due to recurrent laryngeal nerve injury
  • Temporary or permanent hypocalcaemia due to parathyroid gland injury
  • Difficulty swallowing
  • Neck pain or stiffness
  • Scar formation
  • Side effects related to radioactive iodine therapy
  • Dry mouth or altered taste
  • Low thyroid hormone levels requiring lifelong replacement therapy
  • Cancer recurrence
  • Rare complications related to anaesthesia
  • The treating team will explain the potential risks based on the patient's diagnosis, treatment plan, and overall health.

    Patients should share all relevant medical records with the treating oncology and endocrine surgery team before travelling. These may include thyroid ultrasound reports, fine-needle aspiration biopsy results, pathology reports, CT or MRI findings if available, blood tests including thyroid function tests, previous treatment records, current medications, and allergy history.Patients should also discuss the planned surgery, possible radioactive iodine therapy, expected hospital stay, recovery period, thyroid hormone replacement, and follow-up schedule before making travel arrangements.

    Yes. International patients can arrange an online consultation with an endocrine surgeon, endocrinologist, or thyroid cancer specialist before travelling to South Korea. The specialist may review the patient's biopsy reports, imaging findings, laboratory results, tumour stage, and overall clinical condition to recommend an appropriate treatment plan.MediGence can help coordinate online consultations and facilitate the secure sharing of relevant medical records with suitable specialists.

    International patients should carry a valid passport and relevant medical documents, including:
  • Thyroid ultrasound reports
  • Fine-needle aspiration (FNA) biopsy and pathology reports
  • CT, MRI, or PET-CT reports, if available
  • Thyroid function test results
  • Previous endocrinology and surgical consultation records
  • Recent blood test results
  • Current prescriptions and medication details
  • Allergy and complete medical history
  • Previous surgery or cancer treatment records, if applicable
  • The required stay in South Korea depends on the treatment plan, extent of surgery, need for radioactive iodine therapy, and postoperative recovery. Thyroid surgery generally requires a short hospital stay, while radioactive iodine therapy and follow-up assessments may require additional time.Patients may need to remain in South Korea until surgical recovery is satisfactory, calcium and thyroid hormone levels are stable, wound healing is appropriate, and the treating team confirms that the patient is fit to travel.

    Recovery after thyroid surgery generally takes a few weeks, although most patients resume light daily activities within one to two weeks. Recovery may be longer if extensive lymph node surgery or additional treatments are required.Long-term follow-up includes thyroid hormone replacement therapy, thyroglobulin monitoring, neck ultrasound examinations, periodic imaging when indicated, and regular endocrinology or oncology consultations to monitor for recurrence.

    If complications occur, patients should contact the treating medical team or seek immediate medical attention. Prompt evaluation may be required for severe neck swelling, breathing difficulty, persistent hoarseness, fever, excessive bleeding, wound infection, symptoms of low calcium such as numbness or muscle cramps, or signs of thyroid hormone imbalance.Patients should receive detailed discharge instructions, medication guidance, wound care instructions, emergency contact information, and a structured follow-up plan before returning home.

    International patients can submit their medical records, pathology reports, and imaging studies through the MediGence website. Following an initial review, the MediGence care team can help patients explore suitable thyroid cancer centres and experienced specialists, coordinate consultations, and support treatment planning and medical travel arrangements.The final treatment recommendation is made by the treating multidisciplinary team after a comprehensive clinical evaluation.

    International patients may choose South Korea for access to experienced endocrine surgeons, specialised thyroid cancer programmes, advanced diagnostic imaging, nuclear medicine facilities, minimally invasive surgical techniques where appropriate, and comprehensive long-term follow-up services.The destination should be evaluated based on physician expertise, hospital accreditation, patient safety standards, access to advanced thyroid cancer treatments, and experience in managing differentiated thyroid cancers.

    Treatment options depend on the stage of the disease, tumour characteristics, lymph node involvement, risk of recurrence, and overall health. Options may include:
  • Active surveillance for selected low-risk patients
  • Thyroid lobectomy
  • Total thyroidectomy
  • Central or lateral neck lymph node dissection
  • Radioactive iodine (RAI) therapy
  • Thyroid hormone suppression therapy
  • Targeted therapy for advanced or radioactive iodine-refractory disease
  • External beam radiation therapy for selected cases
  • Long-term endocrinology and oncology follow-up
  • The treating multidisciplinary team will recommend the most appropriate treatment plan after evaluating the patient's diagnosis and overall clinical condition.

    International patients may choose South Korea for access to specialised endocrine surgery centres, experienced thyroid cancer specialists, advanced diagnostic technologies, nuclear medicine expertise, personalised treatment planning, and comprehensive long-term thyroid cancer surveillance.MediGence can assist patients with hospital and specialist selection, medical record coordination, consultation scheduling, treatment planning, and travel-related support. The final destination should be selected according to the patient's diagnosis, cancer stage, clinical requirements, treatment goals, and the hospital's expertise in Papillary Thyroid Cancer Treatment.

    Not Sure About Your Treatment Plan? Get a Free Second Opinion

    Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.

    Upload Your Reports
    Free second opinion on your CAR-T plan